Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Expenditure on Health (% of GDP), 2008-2013
Figure 3-2: Total Expenditure on Health per capita (PPP int.US$), 2008-2013
Figure 3-3: Share of Government and Private Expenditure (2012)
Figure 3-4: Government Expenditure on Health (% of total expenditure), 2008-2012
Figure 3-5: Private Expenditure on Health (% of total expenditure), 2008-2012
Figure 3-6: Number of Clinical Trials (2008-2014)
Figure 3-7: Annual Disposable Income (Million US$), 2010-2014
Figure 3-8: Disposable Income Brackets (%), 2012
Figure 3-9: Population above 65 Years (Million), 2008-2013
Figure 5-1: Share of Brazilian Pharmaceutical Market in Latin America (2013)
Figure 5-2: Pharmaceutical Production (Million US$), 2011-2013
Figure 5-3: Pharmaceutical Production Share by Use (2013)
Figure 5-4: Pharmaceutical Production by Use (Million US$), 2012 & 2013
Figure 5-5: Pharmaceutical Production by Ingredients (Million US$), 2012 & 2013
Figure 5-6: Pharmaceutical Production Share by Ingredients (2013)
Figure 5-7: Pharmaceutical Trade (Million US$), 2011-2013
Figure 5-8: Pharmaceutical Market (Billion US$), 2013-2018
Figure 5-9: Pharmaceutical Sales Volume (Billion Units), 2008-2013
Figure 6-1: Pharmaceutical Market Share by Segments (2013)
Figure 6-2: Pharmaceutical Market Share by Segments (2018)
Figure 6-3: OTC Drugs Market (Billion US$), 2013-2018
Figure 6-4: OTC Market Segmentation by Category (2013)
Figure 6-5: Generics Market (Billion US$), 2013-2018
Figure 6-6: Generics Drug Sales by Volume (Million Units), 2008-2013
Figure 6-7: Generics Drug Laboratories (2010-2013)
Figure 6-8: Generics Drug Market by Country of Origin (%), 2013
Figure 6-9: Number of Generics Drugs Registered by Company (2013)
Figure 6-10: Prescription Drugs Market Segmentation (2013)
Figure 6-11: Prescription Drugs Market (Billion US$), 2013-2018
Figure 7-1: Number of HIV Cases Registered ('000), 2005 & 2013
Figure 7-2: HIV Infection Rate in Adult Population (%), 2013 & 2030
Figure 7-3: Diabetic Patients in Age Group 20-79 Years (Million), 2013 & 2030
Figure 9-1: Share of Domestic and International Players (2013)
Figure 9-2: Market Share of Leading Players in Brazilian Pharmaceutical Market (2013)
Figure 10-1: Hypermarcas - Revenue Share by Business Segments (2013)
Figure 10-2: Ache Laboratories - Revenue Share by Business Segments (2013)
Figure 10-3: Sanofi-Aventis - Revenue by Business Segments (Million US$), 2012 & 2013
Figure 10-4: Sanofi-Aventis - Revenue Share by Geographical Regions (2013)
Figure 10-5: Sanofi-Aventis - Revenue Share by Different Regions in Emerging Market (2013)
Figure 10-6: Roche - Revenue Share by Business Segments (2013)
Figure 10-7: Roche - Revenue Share by Therapeutic Segments (2013)
Figure 10-8: Roche - Pharmaceutical Revenue Share by Geographical Regions (2013)
Figure 10-9: Novartis - Revenue Share by Business Segments (2013)
Figure 10-10: Novartis - Pharmaceutical Revenue Share by Geographical Regions (2013)
Figure 10-11: Pfizer - Revenue Share by Business Segments (2013)
Figure 10-12: Pfizer - Revenue Share by Geographical Regions (2013)
Figure 10-13: Merck Group - Revenue Share of Biopharmaceuticals by Geographic Regions (2013)
Figure 10-14: Merck Group - Revenue Share of OTC by Geographic Regions (2013)

List of Tables:

Table 3-1: Household Disposable Income Brackets (‘000), 2012
Table 5-1: Ranking of Medications by Sales (2013)
Table 6-1: Number of Generics Drugs by Country (2013)
Table 7-1: Prevalence of Overweight and Obesity by Gender (%), 2013
Table 10-1: Hypermarcas - Revenue by Business Segments (Million US$), 2012 & 2013
Table 10-2: Ache Laboratories - Revenue by Business Segments (Million US$), 2012 & 2013
Table 10-3: Novartis - Revenue by Business Segments (Million US$), 2012 & 2013
Table 10-4: Pfizer - Revenue by Business Segments (Million US$), 2012 & 2013
Table 10-5: Merck Group - Revenue by Business Segments (Million US$), 2012 & 2013